# Alexion Pharmaceuticals, Inc., Boston, MA – FDA Inspections

Source: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015

> Inspection records and compliance data for Alexion Pharmaceuticals, Inc. in Boston, Massachusetts. 7 FDA inspections on record, 2 Form 483s, 1 warning letter, last inspected July 28, 2026.

---

## Details

- Name: Alexion Pharmaceuticals, Inc.
- FEI Number: 3014801948
- Address Line 1: 121 Seaport Blvd
- City: Boston
- State: Massachusetts
- Zip Code: 02210
- Country Name: United States
- Address: 121 Seaport Blvd, Boston, Massachusetts 02210, United States
- Country: United States

## Related Documents

- FDA Inspection 1330676 - Alexion Pharmaceuticals, Inc. - 2026-07-28 — source: FDA, date: July 28, 2026
- FDA Inspection 1326206 - Alexion Pharmaceuticals, Inc. - 2026-07-01 — source: FDA, date: July 1, 2026
- [483 - Alexion Pharmaceuticals, Inc. - 2025-03-07](https://www.keypedia.com/records/483/alexion-pharmaceuticals-inc/a419172e-26c2-47cb-9836-f572daa92416) — source: FDA, date: March 7, 2025
- [FDA Inspection 1262947 - Alexion Pharmaceuticals, Inc. - 2025-03-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5fb2d391-dc92-43ec-a7a3-bbb58a161055) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2025
- FDA Inspection 1262947 - Alexion Pharmaceuticals, Inc. - 2025-03-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2025
- [483 - Alexion Pharmaceuticals, Inc. - 2024-11-07](https://www.keypedia.com/records/483/alexion-pharmaceuticals-inc/5c1598d5-e9ae-4a35-a2ce-a0faf49e2c58) — source: FDA, date: November 7, 2024
- [FDA Inspection 1254018 - Alexion Pharmaceuticals, Inc. - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5b301914-bf94-449d-9b3e-8f8c86990b4e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2024
- FDA Inspection 1254018 - Alexion Pharmaceuticals, Inc. - 2024-11-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2024
- FDA Inspection 1219061 - Alexion Pharmaceuticals, Inc. - 2023-09-14 — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2023
- FDA Inspection 1218199 - Alexion Pharmaceuticals, Inc. - 2023-06-30 — classification: No Action Indicated (NAI), source: FDA, date: June 30, 2023
- FDA Inspection 1160097 - Alexion Pharmaceuticals, Inc. - 2021-12-17 — classification: No Action Indicated (NAI), source: FDA, date: December 17, 2021
- [WARNING_LETTER - Alexion Pharmaceuticals, Inc. - 2012-08-06](https://www.keypedia.com/records/warning_letter/alexion-pharmaceuticals-inc/87338350-6bc1-4400-affa-2b9ced0020aa) — source: FDA, date: August 6, 2012

## Related Companies

- [Partner Therapeutics, Inc.](https://www.keypedia.com/companies/partner-therapeutics-inc/02b6f3e3-ef3e-4352-9f94-1e462de5f2b4)
- [Alnylam Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a)
- [Aveo Pharmaceuticals Inc.](https://www.keypedia.com/companies/aveo-pharmaceuticals-inc/a2eaa018-1540-42fe-9d11-7e0e3b465daa)
- [Karyopharm Therapeutics Inc.](https://www.keypedia.com/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a)
- [Blueprint Medicines Corporation](https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa)
- [Exemplar Pharmaceuticals LLC](https://www.keypedia.com/companies/exemplar-pharmaceuticals-llc/151a6f00-549b-403b-b79f-3d979f6246b5)
- [Citius Pharmaceuticals, Inc.](https://www.keypedia.com/companies/citius-pharmaceuticals-inc/1aa4934c-96a3-4ecb-a923-8ecd4e362d62)
- [Verastem, Inc.](https://www.keypedia.com/companies/verastem-inc/d477d311-6bcc-4a68-ba12-e2255081e340)
- [Servier Pharmaceuticals, LLC.](https://www.keypedia.com/companies/servier-pharmaceuticals-llc/d72f7c9b-a32a-4c7c-97aa-89001e1341aa)
- [Creighton University IRB](https://www.keypedia.com/companies/creighton-university-irb/d88797ef-211c-4c3e-a162-bccbcf9ca641)

## Related Officers

- [District Director](https://www.keypedia.com/people/mutahar-shamsi/f1ed0c75-3167-41cb-a918-130aa6d0fb07)
- [Scott C. Nickerson](https://www.keypedia.com/people/scott-c-nickerson/a7c7320e-c218-4be2-b657-99bf86371198)
- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)
- [Meredith L. Miller](https://www.keypedia.com/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)
